List of insiders holdings for GYRE THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| GNI Group Ltd. GNI USA Inc. 10% Owner | 2024-01-24 17:11:14 | 73,313,885 0 | 73,313,885 | Form 13D |
| Luo Ying Director | 2024-09-06 08:15:45 | 8,458,983 0 | 8,458,983 | Form 13D |
| PERRY MARK W 10% Owner | 2008-01-18 19:09:46 | 0 5,865,512 | 5,865,512 | Form 4 |
| NEWHALL CHARLES W III 10% Owner | 2008-01-18 19:10:00 | 0 5,865,512 | 5,865,512 | Form 4 |
| TRAINOR III EUGENE A 10% Owner | 2008-01-18 19:11:23 | 0 5,863,512 | 5,863,512 | Form 4 |
| NEA PARTNERS 10 L P 10% Owner | 2008-01-18 19:12:24 | 0 5,863,512 | 5,863,512 | Form 4 |
| GNI Hong Kong Ltd 10% Owner | 2023-10-27 19:56:00 | 5,371,304 0 | 5,371,304 | Form 4 |
| KRAMLICH C RICHARD 10% Owner | 2012-11-20 15:50:33 | 0 4,568,845 | 4,568,845 | Form 4 |
| BARRETT M JAMES 10% Owner | 2013-12-05 15:07:55 | 0 4,563,512 | 4,563,512 | Form 4 |
| SANDELL SCOTT D 10% Owner | 2013-12-05 15:15:07 | 0 4,563,512 | 4,563,512 | Form 4 |
| BARRIS PETER J 10% Owner | 2013-12-05 15:15:46 | 0 4,563,512 | 4,563,512 | Form 4 |
| MORRIS PETER 10% Owner | 2007-02-08 18:07:21 | 0 3,265,512 | 3,265,512 | Form 4 |
| Ma Songjiang President | 2024-12-19 16:01:39 | 0 2,938,467 | 2,938,467 | Form 4 |
| Himawan Jeff Director 10% Owner | 2015-08-20 18:10:32 | 0 2,405,871 | 2,405,871 | Form 4 |
| Ye Weiguo Chief Operating Officer | 2023-11-22 19:49:12 | 1,665,115 0 | 1,665,115 | Form 4 |
| Essex Woodlands Health Ventures VIII L.L.C. Essex Woodlands Health Ventures VIII L.P. 10% Owner | 2015-08-31 15:30:59 | 1,226,519 0 | 1,226,519 | Form 13D |
| JFL Capital Management LLC 5% owner | 2019-02-11 13:38:24 | 839,070 0 | 839,070 | Form 13G |
| HANHAM ANN Director | 2006-04-18 15:48:48 | 0 779,062 | 779,062 | Form 4 |
| EuclidSR Partners L.P. EuclidSR Associates L.P. 10% Owner | 2010-02-02 17:58:51 | 556,631 0 | 556,631 | Form 13G |
| NOMURA INTERNATIONAL PLC Nomura Phase4 Ventures GP LTD Nomura Phase4 Ventures LP Nomura Phase4 Ventures LTD 10% Owner | 2010-02-12 14:29:20 | 519,716 0 | 519,716 | Form 13G |
| EuclidSR Biotechnology Associates L.P. EuclidSR Biotechnology Partners L.P. 10% Owner | 2006-04-18 17:59:57 | 371,748 0 | 371,748 | Form 4 |
| Ying Han Chief Executive Officer | 2024-08-16 20:50:24 | 341,000 0 | 341,000 | Form 4 |
| USMAN NASSIM Director | 2024-07-01 18:00:33 | 279,836 640 | 280,476 | Form 4 |
| Wu Charles C Chief Executive Officer | 2023-11-22 19:20:00 | 170,417 0 | 170,417 | Form 4 |
| deBethizy J Donald President and CEO | 2012-05-08 17:51:31 | 135,000 0 | 135,000 | Form 4 |
| Zorn Peter A SVP, Lgl Affrs, GC & Secretary | 2013-01-18 17:26:31 | 65,000 0 | 65,000 | Form 4 |
| Brennan Jeffrey P SVP, Bus. and Comm. Dev. & CBO | 2013-01-18 17:16:12 | 65,000 0 | 65,000 | Form 4 |
| Madison Edwin Chief Scientific Officer | 2015-12-15 17:37:53 | 58,572 0 | 58,572 | Form 4/A |
| Musso Alan A SVP, Fin+Admin, CFO & Treas | 2014-10-21 16:22:28 | 57,799 0 | 57,799 | Form 4 |
| Dunbar Geoffrey C SVP, Clin. Dev. & Reg. Affairs | 2011-03-31 19:10:31 | 55,500 0 | 55,500 | Form 4 |
| Musil Clinton Chief Financial Officer | 2021-04-26 17:38:43 | 54,000 0 | 54,000 | Form 4/A |
| Nussbaum Rodney L Director | 2024-08-16 21:13:29 | 52,000 0 | 52,000 | Form 4 |
| Parry Renate Director | 2024-08-16 21:10:28 | 52,000 0 | 52,000 | Form 4 |
| Epstein David M. Director | 2024-08-16 21:07:51 | 52,000 0 | 52,000 | Form 4 |
| Carmichael Gordon Director | 2024-08-16 21:05:18 | 52,000 0 | 52,000 | Form 4 |
| Chen Ruoyu Chief Financial Officer | 2024-08-16 20:53:18 | 50,000 0 | 50,000 | Form 4 |
| Rock Patrick C. Secretary, GC | 2015-08-18 15:38:44 | 48,553 0 | 48,553 | Form 4 |
| Toler Steven M. VP, Clin Pharm Sciences | 2014-10-21 16:21:16 | 46,000 0 | 46,000 | Form 4 |
| Hosford David A. VP, Clin Dev & Reg Affairs | 2014-01-24 17:01:42 | 45,000 0 | 45,000 | Form 4 |
| Hodges Mauri K Treasurer, CFO | 2015-08-18 15:34:17 | 44,516 0 | 44,516 | Form 4 |
| Hicks Karen A VP, Human Resources | 2013-01-18 17:17:46 | 40,000 0 | 40,000 | Form 4 |
| Bencherif Merouane SVP and Senior Scien Fellow | 2013-01-18 17:14:41 | 40,000 0 | 40,000 | Form 4 |
| Williams Eddie Director | 2022-01-07 17:33:42 | 34,804 0 | 34,804 | Form 4 |
| Ling Geoffrey M.D. Director | 2022-01-07 17:31:57 | 31,790 0 | 31,790 | Form 4 |
| DESOUZA ERROL B Director | 2021-10-05 16:32:07 | 29,801 0 | 29,801 | Form 4 |
| JEW JEANNE Y Director | 2021-09-13 20:13:11 | 28,000 0 | 28,000 | Form 4 |
| Jones Elaine V Former Director as of 6/13/07 Director | 2008-02-25 16:39:55 | 27,500 0 | 27,500 | Form 4/A |
| Eastling Thomas Wilson Director | 2024-08-16 20:58:39 | 26,000 0 | 26,000 | Form 4 |
| Levy Howard Chief Medical Officer | 2021-08-11 09:14:29 | 639 23,390 | 24,029 | Form 4 |
| SKALETSKY MARK B Director | 2013-06-10 15:23:12 | 17,500 0 | 17,500 | Form 4 |
| BROWN JULIA R Director | 2015-08-18 15:39:02 | 17,263 0 | 17,263 | Form 4 |
| TETLOW SHARON Director | 2021-07-02 09:55:42 | 14,000 0 | 14,000 | Form 4 |
| SELICK HAROLD E Director | 2018-01-18 18:03:05 | 11,697 0 | 11,697 | Form 4 |
| DUNTON ALAN W Director | 2015-08-18 15:34:08 | 10,789 0 | 10,789 | Form 4 |
| BLIXT CHARLES A Director | 2015-08-18 15:35:38 | 10,789 0 | 10,789 | Form 4 |
| Blouse Grant E. Chief Scientific Officer | 2022-08-10 17:17:57 | 9,417 0 | 9,417 | Form 4 |
| Caldwell William S SVP - Drug Discovery and Dev. | 2011-09-29 14:42:32 | 6,735 2,500 | 9,235 | Form 4 |
| SNYDERMAN RALPH Director | 2012-06-08 17:15:46 | 7,500 0 | 7,500 | Form 4 |
| Cai Veronica Controller | 2020-03-13 18:55:34 | 7,353 0 | 7,353 | Form 4 |
| BURRILL STEVEN Director | 2012-08-01 17:22:32 | 0 4,333 | 4,333 | Form 4 |
| Richard John P Director | 2020-03-13 18:56:17 | 3,716 0 | 3,716 | Form 4 |
| HILL STEPHEN A Director | 2018-09-06 21:41:02 | 1,190 0 | 1,190 | Form 4 |
| Flynn James E Deerfield Mgmt L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Special Situations Fund L.P. DEERFIELD PARTNERS L.P. Possible Member of 10% Group 10% Owner | 2019-02-12 16:11:58 | 0 0 | 0 | Form 13G |
| NEW ENTERPRISE ASSOCIATES 10 L P 10% Owner | 2017-05-23 17:20:54 | 0 0 | 0 | Form 13D |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INC LAMPERT MARK N BVF INVESTMENTS LLC INVESTMENT 10 LLC See Explanation of Responses | 2017-02-14 12:53:49 | 0 0 | 0 | Form 13G |
| Miller Seline E. SVP Finance; Interim CFO & PAO | 2023-09-01 16:07:11 | 0 0 | 0 | Form 4 |
| LAWLOR AUGUSTINE Director | 2023-09-01 16:07:04 | 0 0 | 0 | Form 4 |
| Hunt Andrea Director | 2023-09-01 16:07:08 | 0 0 | 0 | Form 4 |
| Payne Fletcher Chief Financial Officer | 2019-09-25 14:03:29 | 0 0 | 0 | Form 4 |